Education
About Us
Working with TipRanks
Follow Us
Clearpoint Neuro, Inc. (CLPT)
:CLPT
CLPT Stock Chart & Stats
$27.32
-$0.35(-2.27%)
At close: 4:00 PM EST
$27.32
-$0.35(-2.27%)
Day’s Range― - ―
52-Week Range$9.76 - $30.10
Previous CloseN/A
Volume88.39K
Average Volume (3M)851.57K
Market Cap
$390.54M
Enterprise Value$616.96M
Total Cash (Recent Filing)$38.22M
Total Debt (Recent Filing)$35.74M
Price to Earnings (P/E)―
Beta1.60
Next Earnings
Mar 04, 2026EPS Estimate
-0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding28,423,307
10 Day Avg. Volume482,046
30 Day Avg. Volume851,569
Financial Highlights & Ratios
PEG Ratio0.99
Price to Book (P/B)16.37
Price to Sales (P/S)13.24
P/FCF Ratio-45.06
Enterprise Value/Market Cap1.58
Enterprise Value/Revenue17.97
Enterprise Value/Gross Profit29.31
Enterprise Value/Ebitda-28.91
Forecast
1Y Price Target
$29.00Price Target Upside6.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.81
Revenue Forecast (FY)$37.65M
Bulls Say, Bears Say
Bulls Say
Balance SheetThe balance sheet is solid with over $20M of cash and no debt.
EarningsFunctional Neuro growth was strong at 43% year-over-year.
Partnership DevelopmentsThe partner business recently had significant developments that accelerate $100s of millions of revenue opportunities, with 70%+ gross margins.
Bears Say
Market Entry TimingRevenue opportunities from the partner business are expected to be on the market as early as late 2026.
ClearPoint Neuro News
CLPT FAQ
What was Clearpoint Neuro, Inc.’s price range in the past 12 months?
Clearpoint Neuro, Inc. lowest stock price was $9.76 and its highest was $30.10 in the past 12 months.
What is Clearpoint Neuro, Inc.’s market cap?
Clearpoint Neuro, Inc.’s market cap is $390.54M.
When is Clearpoint Neuro, Inc.’s upcoming earnings report date?
Clearpoint Neuro, Inc.’s upcoming earnings report date is Mar 04, 2026 which is in 91 days.
How were Clearpoint Neuro, Inc.’s earnings last quarter?
Clearpoint Neuro, Inc. released its earnings results on Nov 06, 2025. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.205 by -$0.005.
Is Clearpoint Neuro, Inc. overvalued?
According to Wall Street analysts Clearpoint Neuro, Inc.’s price is currently Undervalued.
Does Clearpoint Neuro, Inc. pay dividends?
Clearpoint Neuro, Inc. does not currently pay dividends.
What is Clearpoint Neuro, Inc.’s EPS estimate?
Clearpoint Neuro, Inc.’s EPS estimate is -0.2.
How many shares outstanding does Clearpoint Neuro, Inc. have?
Clearpoint Neuro, Inc. has 28,423,307 shares outstanding.
What happened to Clearpoint Neuro, Inc.’s price movement after its last earnings report?
Clearpoint Neuro, Inc. reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.205. Following the earnings report the stock price went down -13.275%.
Which hedge fund is a major shareholder of Clearpoint Neuro, Inc.?
Currently, no hedge funds are holding shares in CLPT
ClearPoint Neuro Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$29.00 (6.15% Upside)
$29.00 (6.15% Upside)
Blogger Sentiment
Bullish
CLPT Sentiment 70%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 14.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.9%
Last 30 Days ▲ 9.5%
Last 30 Days ▲ 9.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.07%
12-Months-Change
Fundamentals
Return on Equity
-103.13%
Trailing 12-Months
Asset Growth
50.17%
Trailing 12-Months
Company Description
Clearpoint Neuro, Inc.
ClearPoint Neuro (CLPT) is a medical technology company focused on developing and commercializing innovative solutions for neurosurgery. The company operates primarily in the healthcare sector, specializing in brain disease therapies and neurosurgical navigation systems. ClearPoint Neuro's core products include its proprietary ClearPoint System, which enables precision targeting and delivery of therapies to the brain, and its suite of neuro-navigation tools designed to enhance surgical accuracy and safety.
CLPT Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted several strategic advancements, including a merger with IRRAS and revenue growth across key segments. However, challenges such as increased operating expenses and a temporary slowdown in revenue growth due to facility transitions were noted. Overall, the strategic positioning and growth initiatives suggest a positive outlook.View all CLPT earnings summariesCLPT Stock 12 Month Forecast
Average Price Target
$29.00
▲(6.15% Upside)
Technical Analysis
Ownership Overview
10.59% Insiders
8.63% Mutual Funds
4.55% Other Institutional Investors
67.80% Public Companies and Individual Investors